140 related articles for article (PubMed ID: 6299689)
1. Biological activities and receptor interactions of des-Leu16 salmon and des-Phe16 human calcitonin.
Findlay DM; Michelangeli VP; Orlowski RC; Martin TJ
Endocrinology; 1983 Apr; 112(4):1288-91. PubMed ID: 6299689
[TBL] [Abstract][Full Text] [Related]
2. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
[TBL] [Abstract][Full Text] [Related]
3. Conformational requirements for activity of salmon calcitonin.
Findlay DM; Michelangeli VP; Martin TJ; Orlowski RC; Seyler JK
Endocrinology; 1985 Sep; 117(3):801-5. PubMed ID: 4017965
[TBL] [Abstract][Full Text] [Related]
4. Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane-loop regions.
Stroop SD; Nakamuta H; Kuestner RE; Moore EE; Epand RM
Endocrinology; 1996 Nov; 137(11):4752-6. PubMed ID: 8895343
[TBL] [Abstract][Full Text] [Related]
5. Biologically active, derivatizable salmon calcitonin analog: design, synthesis, and applications.
D'Santos CS; Nicholson GC; Moseley JM; Evans T; Martin TJ; Kemp BE
Endocrinology; 1988 Sep; 123(3):1483-8. PubMed ID: 2841096
[TBL] [Abstract][Full Text] [Related]
6. des-Ser2 salmon calcitonin: a biologically potent synthetic analog.
Schwartz KE; Orlowski RC; Marcus R
Endocrinology; 1981 Mar; 108(3):831-5. PubMed ID: 6257497
[TBL] [Abstract][Full Text] [Related]
7. Properties of a calcitonin receptor and adenylate cyclase in BEN cells, a human cancer cell line.
Findlay DM; deLuise M; Michelangeli VP; Ellison M; Martin TJ
Cancer Res; 1980 Apr; 40(4):1311-7. PubMed ID: 6244091
[TBL] [Abstract][Full Text] [Related]
8. Homologous desensitization of calcitonin receptors and calcitonin-dependent adenylate cyclase in T47D cells.
Schneider HG; Raue F; Koppold A; Ruf W; Ziegler R
Acta Endocrinol (Copenh); 1993 Apr; 128(4):373-8. PubMed ID: 8388616
[TBL] [Abstract][Full Text] [Related]
9. Renal receptors for calcitonin: coordinate occurrence with calcitonin-activated adenylate cyclase.
Marx SJ; Aurbach GD
Endocrinology; 1975 Aug; 97(2):448-53. PubMed ID: 169126
[TBL] [Abstract][Full Text] [Related]
10. Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues.
Taylor JW; Jin QK; Sbacchi M; Wang L; Belfiore P; Garnier M; Kazantzis A; Kapurniotu A; Zaratin PF; Scheideler MA
J Med Chem; 2002 Feb; 45(5):1108-21. PubMed ID: 11855991
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines.
Findlay DM; Michelangeli VP; Eisman JA; Frampton RJ; Moseley JM; MacIntyre I; Whitehead R; Martin TJ
Cancer Res; 1980 Dec; 40(12):4764-7. PubMed ID: 6254651
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and utility of novel benzophenone-containing calcitonin analogs for photoaffinity labeling the calcitonin receptor.
Suva LJ; Flannery MS; Caulfield MP; Findlay DM; Jüppner H; Goldring SR; Rosenblatt M; Chorev M
J Pharmacol Exp Ther; 1997 Nov; 283(2):876-84. PubMed ID: 9353409
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin induction of a persistent activated state of adenylate cyclase in human breast cancer cells (T 47D).
Lamp SJ; Findlay DM; Moseley JM; Martin TJ
J Biol Chem; 1981 Dec; 256(23):12269-74. PubMed ID: 6271778
[No Abstract] [Full Text] [Related]
14. Relationship between internalization and calcitonin-induced receptor loss in T 47D cells.
Findlay DM; Martin TJ
Endocrinology; 1984 Jul; 115(1):78-83. PubMed ID: 6329663
[TBL] [Abstract][Full Text] [Related]
15. Deletion sequences of salmon calcitonin that retain the essential biological and conformational features of the intact molecule.
Epand RM; Epand RF; Stafford AR; Orlowski RC
J Med Chem; 1988 Aug; 31(8):1595-8. PubMed ID: 3397998
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase-C-induced down-regulation of calcitonin receptors and calcitonin-activated adenylate cyclase in T47D and BEN cells.
Findlay DM; Michelangeli VP; Robinson PJ
Endocrinology; 1989 Nov; 125(5):2656-63. PubMed ID: 2551660
[TBL] [Abstract][Full Text] [Related]
17. Action of calcitonin gene-related peptide at the calcitonin receptor of the T47D cell line.
Raue F; Schneider HG; Zink A; Ziegler R
Horm Metab Res; 1987 Nov; 19(11):563-4. PubMed ID: 2828211
[TBL] [Abstract][Full Text] [Related]
18. Isoforms of the rat calcitonin receptor: consequences for ligand binding and signal transduction.
Houssami S; Findlay DM; Brady CL; Myers DE; Martin TJ; Sexton PM
Endocrinology; 1994 Jul; 135(1):183-90. PubMed ID: 8013352
[TBL] [Abstract][Full Text] [Related]
19. Evidence for calcitonin receptor heterogeneity: binding studies with nonhelical analogs.
Nakamuta H; Orlowski RC; Epand RM
Endocrinology; 1990 Jul; 127(1):163-9. PubMed ID: 2163309
[TBL] [Abstract][Full Text] [Related]
20. The calcitonin receptor: characterization and processing.
Raue F; Schneider HG; Ziegler R
Prog Clin Biol Res; 1990; 332():67-79. PubMed ID: 2158663
[No Abstract] [Full Text] [Related]
[Next] [New Search]
